scholarly journals Long-term (8 year) outcomes and predictors of major adverse cardiac events after full metal jacket drug-eluting stent implantation

2014 ◽  
Vol 84 (3) ◽  
pp. 361-365 ◽  
Author(s):  
Cheol Whan Lee ◽  
Jung-Min Ahn ◽  
Jong-Young Lee ◽  
Won-Jang Kim ◽  
Duk-Woo Park ◽  
...  
Keyword(s):  
Stent Implantation ◽  
Major Adverse Cardiac Events ◽  
Drug Eluting Stent ◽  
Cardiac Events ◽  
Adverse Cardiac Events ◽  
Drug Eluting ◽  
Full Metal Jacket

scholarly journals The ‘all comer’ Coroflex Please drug-eluting stent registry in Europe and Asia – An overall and transcontinental assessment of the 10-month major adverse cardiac events

2012 ◽  
Vol 64 (5) ◽  
pp. 453-461 ◽  
Author(s):  
Matthias Leschke ◽  
Vo Thanh Nhan ◽  
Matthias Waliszewski ◽  
Vicente Palacios ◽  
Iván Horváth ◽  
...  
Keyword(s):  
Major Adverse Cardiac Events ◽  
Drug Eluting Stent ◽  
Cardiac Events ◽  
Adverse Cardiac Events ◽  
Drug Eluting

Abstract 1691: Stages of Chronic Kidney Disease Correlate with Major Adverse Cardiac Events as well as Late Lumen Loss Following the Sirolimus Eluting Coronary Stent

Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Yota Kawamura ◽  
Yoshihiro Morino ◽  
Masakazu Nagaoka ◽  
Takashi Matsukage ◽  
Naoki Masuda ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Stent Implantation ◽  
Major Adverse Cardiac Events ◽  
Drug Eluting Stent ◽  
Maximum Pressure ◽  
Cardiac Events ◽  
Late Lumen Loss ◽  
Adverse Cardiac Events

Background: Chronic Kidney Disease (CKD) is considered as a risk factor for development of cardiovascular disease. However, it is unclear whether CKD has association with prognosis following the drug eluting stent implantation. Methods and Results : The Cypher coronary stents were implanted to 302 lesions in 249 patients who underwent elective PCI between January 2005 and April 2006. Average age was 66.3 ± 9.7 and male gender was 80.3%. Diabetes was found in 47% of the patients including 16% of insulin treatment. Stages of CKD are shown in the table 1 and 2 . AHA/ACC lesion type B2/C was 62%. Cypher stents were implanted at maximum pressure at 17.3 ± 3.0 atm. Intravascular ultrasound was used in 92% of the procedure. Clinical follow-up data were available in 89.9 % at 1 year although angiographic follow-up was performed in 73.1% at 8 months. Major adverse cardiac events were frequently observed in association with stages of CKD as shown in the table 1 . Stages of CKD have correlation with late lumen loss at 8 months (Table 2 ). Furthermore, in-stent late lumen loss inversely correlated with glomerular filtration rate (GFR) (R = −0.18, p = 0.0097). Conclusion : Stages of CKD have correlation with major adverse cardiac events as well as late lumen loss following the sirolimus eluting stent implantation. Clinical follow-up at 1 year of study stratified by stages of CKD Angiographic data of study stratified by stages of CKD

Predictors of Long-Term Major Adverse Cardiac Events and Clinical Restenosis following Elective Percutaneous Coronary Stenting

Angiology ◽  
2008 ◽  
Vol 60 (2) ◽  
pp. 141-147 ◽  
Author(s):  
Qiangjun Cai ◽  
Kimberly Skelding ◽  
Armstrong Arthur ◽  
Dipan Desai ◽  
G. Craig Wood ◽  
...  
Keyword(s):  
Bare Metal Stents ◽  
Coronary Intervention ◽  
Major Adverse Cardiac Events ◽  
Metal Stents ◽  
Cardiac Events ◽  
Elective Percutaneous Coronary Intervention ◽  
Adverse Cardiac Events ◽  
Percutaneous Coronary ◽  
Drug Eluting

Limited data exist regarding the predictors of long-term clinical outcomes following elective percutaneous coronary intervention (PCI) in the current era of stenting. The authors investigated the predictors of major adverse cardiac events (MACE) and clinical restenosis in 740 consecutive patients who underwent successful elective PCI with bare metal stents (BMSs) or drug-eluting stents (DESs). At 30-month follow -up, compared with BMS recipients, DES recipients had a significantly lower rate of MACE, which was mainly driven by a decreased repeat target vessel PCI. The rate of 30-month clinical restenosis was significantly lower in DES recipients. The authors conclude that baseline clinical, angiographic, and procedural characteristics determine long-term MACE and clinical restenosis after elective PCI, with DES being the independent predictor for both.

Sign in / Sign up

Export Citation Format

Share Document